Beneficient current report, 27 June 2023

Beneficient Form 8-K Summary

Business Context and Reporting Period

Beneficient filed a Current Report on Form 8-K dated June 27, 2023, regarding its entry into a Standby Equity Purchase Agreement with YA II PN, Ltd., an affiliate of Yorkville. Beneficient is a Nevada corporation whose Class A common stock and warrants trade on Nasdaq under the symbols BENF and BENFW. The company is designated as an emerging growth company.

Material Financing Terms and Key Financial Items

  • Yorkville committed to purchase up to $250 million of Beneficient Class A common stock during a 36-month commitment period beginning June 27, 2023.
  • Beneficient may request advances, but is not obligated to sell shares. Each advance is generally limited to the greater of 100% of the company’s Nasdaq trading volume during the preceding five trading days or $10 million, subject to mutual agreement for increases.
  • Shares may be sold at either 95% of the applicable market price under a same-day pricing period or 97% of the lowest VWAP during a three-trading-day pricing period.
  • Yorkville’s ownership is limited to 9.99% of outstanding Class A common stock at the time of an advance. An Exchange Cap generally limits issuances to 19.99% of the company’s outstanding Class A and Class B common stock as of the agreement date, subject to specified exceptions.
  • Beneficient paid a $25,000 structuring fee to a Yorkville subsidiary.
  • Beneficient must pay a $1.25 million commitment fee within three trading days by issuing Class A common stock. The number of shares is based on the commitment fee divided by the Nasdaq closing price on the trading day immediately preceding the agreement.
  • The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-period financial results.

Material Changes, Outlook, Risks, and Unusual Items

  • The SEPA provides potential access to substantial equity capital but does not guarantee that Beneficient will draw any funds.
  • Any drawdown would dilute existing stockholders. The discount to market price and the potentially variable number of shares issued may increase dilution, particularly if the stock price declines.
  • Advances are subject to trading-volume limits. If trading volume falls below the defined threshold, the number of shares sold may be reduced, limiting the amount of capital available.
  • Beneficient must register the shares issuable to Yorkville for resale, and the SEC must declare the registration statement effective before the company may sell shares under the SEPA.
  • Yorkville is subject to restrictions against short-selling and hedging Beneficient’s Class A common stock during the agreement term.
  • The shares described in Item 3.02 are being issued and sold in reliance on the Securities Act Section 4(a)(2) exemption from registration; the filing also requires registration for resale under the SEPA.

Investor Verification Checklist

  • Verify the full terms of the Standby Equity Purchase Agreement filed as Exhibit 10.1.
  • Confirm whether Beneficient filed and obtained effectiveness of the required resale registration statement.
  • Track actual advances, shares issued, pricing discounts, and cumulative dilution.
  • Review the calculation and settlement of the $1.25 million commitment fee.
  • Monitor compliance with the 9.99% ownership limitation, the 19.99% Exchange Cap, and applicable Nasdaq shareholder-approval requirements.
  • Review subsequent filings for the company’s use of proceeds, liquidity needs, and any amendments or termination of the SEPA.